Medacta Corporate
Quadra-H 10 years!

Quadra-H 10 years!

In 2003 a new stem was introduced into the market: Quadra-H. This year we celebrate the 10th year of the Quadra-H stem system along with its clinical success.

In 2003 a new stem was introduced into the market: Quadra®-H. This year we celebrate the 10th year of the Quadra®-H stem system along with its clinical success.

With more than 60,000 stems implanted worldwide it has proved to be a reliable solution for almost every indication of Hip Arthroplasty. From the mechanical tests performed the reports show excellent performance and stability of this stem design on bone1. In a 7 year clinical outcome study the Quadra®-H showed a 100% survival rate when considering aseptic loosening and a 97% survival rate when considering any reason as the endpoint2. It is an excellent straight cementless stem solution which can also be easily implanted via the anterior approach.

Many thanks to the surgeons who work with and support us for without them this success would not be possible.

 

1Thomsen M, Lee C, Jakubowitz E. Lab-Report Quadra-S, Medacta International SA: Measurement of the initial stability, Ortopädische Universitätsklinik Heidelberg, May 25 2006.

2Moreau P. Cementless HA Coated Quadra® stem: 7 years clinical outcomes. M.O.R.E. Journal, 2 3-6, January 2012